Search alternatives:
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 ppm » 5 ppm (Expand Search)
5 c » 25 c (Expand Search)
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 ppm » 5 ppm (Expand Search)
5 c » 25 c (Expand Search)
-
161
-
162
-
163
-
164
-
165
Microstructure Evolution of the Mg-5.8 Zn-0.5 Zr-1.0 Yb Alloy During Homogenization
Published 2022“…After homogenization, most of the eutectic phases dissolve into the matrix, except for a small amount of Mg-Zn-Yb phase. The area fractions of residual secondary phase decrease from 5.54% in the as-cast alloy to 0.59% in the well-homogenized sample. …”
-
166
-
167
-
168
Causes of death as recorded in medical chart reported as percent of total deaths.
Published 2023Subjects: -
169
-
170
-
171
-
172
Image_5_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF
Published 2022“…</p>Methods<p>We included (P) participants, adult PE patients; (I) intervention, CDT; (C) comparison, ST; (O) outcomes, mortality, complications, in-hospital treatment, and length of hospital stay; (S) study design, randomized controlled trials (RCTs), or cohort comparing CDT and ST. …”
-
173
-
174
Toluidine blue histology of cMSC constructs for initial chondrogenic screening.
Published 2022Subjects: -
175
-
176
-
177
-
178
5-year risk of cardiovascular diseases under exposure deciles of A) HbA1C-CV and B) FPG-CV.
Published 2025Subjects: -
179
-
180